Cargando…

Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy

Patients with hypertrophic cardiomyopathy (HCM) may progress to the dilated phase (DHCM). This study aimed to identify the predictive factors for DHCM progression, including left ventricular (LV) ejection fraction (LVEF < 50%) or decreased LV contraction (LVEF < 60%). The study included 291 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishihara, Kakeru, Kubota, Yoshiaki, Matsuda, Junya, Imori, Yoichi, Tokita, Yukichi, Asai, Kuniya, Takano, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420074/ https://www.ncbi.nlm.nih.gov/pubmed/37568539 http://dx.doi.org/10.3390/jcm12155137

Ejemplares similares

Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy
por: Imori, Yoichi, et al.
Publicado: (2019)

Clinical features and long-term prognosis of patients with congestive heart failure taking tolvaptan: a comparison of patients with preserved and reduced left ventricular ejection fraction
por: Seki, Toshiki, et al.
Publicado: (2021)

Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease
por: Watanabe, Yukihiro, et al.
Publicado: (2023)

Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance
por: Suzuki, Keishi, et al.
Publicado: (2016)

Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study
por: Nakamura, Shunichi, et al.
Publicado: (2014)

Effects of Hypertrophic and Dilated Cardiac Geometric Remodeling on Ejection Fraction
por: Zheng, Yu, et al.
Publicado: (2022)

Adjunctive Catheter-Directed Thrombolysis during Primary PCI for ST-Segment Elevation Myocardial Infarction with High Thrombus Burden
por: Noma, Satsuki, et al.
Publicado: (2022)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using (18)F-fluorodeoxyglucose positron emission tomography
por: Aoyama, Rie, et al.
Publicado: (2017)

Relationship of maximum walking speed with peak oxygen uptake and anaerobic threshold in male patients with heart failure
por: Koen, Masahiro, et al.
Publicado: (2023)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
por: Calderon-Dominguez, Maria, et al.
Publicado: (2021)

Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy
por: Yazaki, Mayu, et al.
Publicado: (2023)

Dilated Cardiomyopathy With Mid‐Range Ejection Fraction at Diagnosis: Characterization and Natural History
por: Gentile, Piero, et al.
Publicado: (2019)

Cheyne‐stokes respiration associated with hypertrophic cardiomyopathy and normal left ventricular ejection fraction
por: Pedrosa, Rodrigo P, et al.
Publicado: (2010)

Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction
por: Zhao, Xiaodan, et al.
Publicado: (2018)

Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy
por: Liu, Jie, et al.
Publicado: (2022)

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
por: Mahmod, Masliza, et al.
Publicado: (2022)

Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale
por: Kubota, Yoshiaki, et al.
Publicado: (2018)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
por: El-Zarea, Gehan Abd El-Rahman, et al.
Publicado: (2016)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
por: Chiti, Enrica, et al.
Publicado: (2021)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
por: El Hadi, Hamza, et al.
Publicado: (2023)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Effect of obstructive sleep apnea on right ventricular ejection fraction in patients with hypertrophic obstructive cardiomyopathy
por: Wang, Shengwei, et al.
Publicado: (2020)

Left ventricular hypertrophy, dilatation and ejection fractions predict ventricular tachycardia in amyloid transthyretin cardiomyopathy
por: Knoll, K, et al.
Publicado: (2023)

Characteristics of the right ventricle in left ventricular noncompaction with reduced ejection fraction in the light of dilated cardiomyopathy
por: Gregor, Zsófia, et al.
Publicado: (2023)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

Global Longitudinal Strain as an Efficient Prognostic Tool in Hypertrophic Cardiomyopathy With Preserved Left Ventricular Ejection Fraction
por: Battel, Owen, et al.
Publicado: (2022)

Cardiogenic cerebral embolism due to sinus arrest associated with coronary intervention for the right coronary artery: A case report
por: Seki, Toshiki, et al.
Publicado: (2021)

Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus
por: Hoshika, Yu, et al.
Publicado: (2021)

Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus
por: Mozawa, Kosuke, et al.
Publicado: (2021)

Anaesthetic Management of Renal Transplant Surgery in Patients of Dilated Cardiomyopathy with Ejection Fraction Less Than 40%
por: Srivastava, Divya, et al.
Publicado: (2014)

Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction
por: Aleksova, Aneta, et al.
Publicado: (2019)

The prognostic value of right ventricular longitudinal strain and 3D ejection fraction in patients with dilated cardiomyopathy
por: Vîjîiac, Aura, et al.
Publicado: (2021)

Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction
por: Li, Yumin, et al.
Publicado: (2021)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
por: Colombo, Maria Giovanna, et al.
Publicado: (2008)

Reversible transition from a hypertrophic to a dilated cardiomyopathy
por: Spillmann, Frank, et al.
Publicado: (2015)

Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses
por: Kuno, Toshiki, et al.
Publicado: (2017)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4kcvhstiblq54gqjitqg8g8ama